Moderna Shares Plunge 18% After Melanoma Vaccine Data Leak
Moderna shares fell about 18% after leaked trial data for its melanoma vaccine fell short of elevated Wall Street expectations. The data had been slated for announcement over the weekend.
Site Search
Search market news
Find public news by keyword, exact ticker, category and date.
Matching instruments
Open a ticker page for its news coverage. The news search below stays a text search.